Clopitab-A 150, Aspirin + Clopidogrel, Lifestyle-related Diseases, Cerebral Infarction & Myocardial Infarction, Online Pharmacy

Clopitab-A 150 Capsule

★★★★★

(0)

Generic For	DUOCOVERA
Active Ingredient	ASPIRIN\|CLOPIDOGREL
Strength	150MG\|75MG
Manufacturer	LUPIN LTD

Pack Size	Price Per Unit	Unit Price	Best Coupon Price MAX DISCOUNT
★ Best Value 1 BOX - 300 CAPSULES	$ 0.34	$ 101.90	$ 86.62 Apply ZARVY26 (-15%) You save $ 15.29
★ Best Value 2 BOXES - 600 CAPSULES	$ 0.31	10% $ 203.80 $ 183.80	$ 156.23 Apply ZARVY26 (-15%) You save $ 27.57
★ Best Value 3 BOXES - 900 CAPSULES	$ 0.29	16% $ 305.70 $ 257.50	$ 218.88 Apply ZARVY26 (-15%) You save $ 38.63

Pack Size

Price Per Unit

Unit Price

QTY

CART

Best Coupon Price
MAX DISCOUNT

1 BOX - 300 CAPSULES

$ 0.34

$ 101.90

$ 86.62

Apply ZARVY26 (-15%)

You save $ 15.29

2 BOXES - 600 CAPSULES

$ 0.31

10% $ 203.80

$ 183.80

$ 156.23

Apply ZARVY26 (-15%)

You save $ 27.57

★ Best Value 3 BOXES - 900 CAPSULES

$ 0.29

16% $ 305.70

$ 257.50

$ 218.88

Apply ZARVY26 (-15%)

You save $ 38.63

Product Description

Clopitab-A 150 Capsule combines Aspirin 150 mg and Clopidogrel 75 mg in a dual antiplatelet therapy (DAPT) regimen for enhanced cardiovascular protection. Widely used in patients at elevated thrombotic risk or those not responding adequately to lower-dose aspirin, this combination is essential in post-stent care and ACS management. Aspirin inhibits COX-1 to reduce platelet aggregation, while Clopidogrel selectively blocks the ADP P2Y12 receptor, providing a synergistic effect. ZarvyPharm online pharmacy offers this trusted therapy alongside other cardiovascular agents like Glucophage and Lipidator-A.

Indications & Uses

Lifestyle-related Diseases > Cerebral Infarction & Myocardial Infarction
This dual antiplatelet product is used to prevent blood clots that could lead to heart attack or stroke in patients with established cardiovascular disease. It is especially indicated after stent placement or in patients with a history of ischemic stroke or TIA. The higher aspirin content may be preferred in patients with more aggressive platelet activity or high cardiovascular risk.

Benefits & Effectiveness

Dual mechanism targets thrombotic pathways via COX-1 and P2Y12 inhibition
High-dose aspirin enhances antiplatelet effect in resistant cases
Key agent in ACS treatment and secondary stroke prevention
Reduces incidence of stent thrombosis and recurrent infarctions

Directions for Use

Unstable Angina (UA) / Non-ST-Elevation Myocardial Infarction (NSTEMI) - Clopidogrel Loading Dose: 300 mg orally once, Clopidogrel Maintenance Dose: 75 mg orally once daily, Aspirin Dose: 75–325 mg daily (here as 150 mg fixed), Duration: Often continued for 12 months, based on clinical judgment
ST-Elevation Myocardial Infarction (STEMI) - Clopidogrel Loading Dose: 300 mg orally once (optional), Clopidogrel Maintenance Dose: 75 mg once daily, Aspirin: 150 mg once daily in this formulation, Duration: Typically maintained for 6–12 months post-event
Use - Prevention of atherothrombotic events in ACS (UA, NSTEMI, STEMI), Secondary prevention in patients with established atherosclerotic cardiovascular disease, Often used post-PCI or coronary stent placement
Cautions - Risk of bleeding increases with higher aspirin dose, Avoid use in patients with active bleeding, peptic ulcer disease, or history of hemorrhagic stroke, Discontinue 5–7 days prior to surgery if clinically appropriate, Monitor for signs of GI bleeding or unexplained bruising

Storage

Store in a cool, dry place below 25°C. Keep in original packaging away from moisture and light. Ensure it is kept out of reach of children.

Possible Side Effects

- Increased risk of gastrointestinal bleeding - Epigastric discomfort or ulceration - Bruising, prolonged bleeding from cuts - Rare: Thrombocytopenia, rash, hypersensitivity reactions - Headache or dizziness (uncommon but reported)

FAQs

The main difference is the aspirin content: 75 mg vs. 150 mg. Clopitab-A 150 provides a stronger antiplatelet effect, often used in higher-risk patients.

No, extended-release or fixed-dose combination capsules should not be split or crushed. Always follow your doctor’s instructions.

Yes, under medical supervision. Long-term use is common in patients with prior stent insertion or recurrent vascular events.

Contact your healthcare provider immediately. Do not stop the medication abruptly without consulting your doctor.

Concurrent use with NSAIDs increases the risk of GI bleeding and should be avoided unless prescribed together with protective agents.

Ratings & Reviews

Reviewed by 0 Users

0/5

★★★★★

5★

4★

3★

2★